Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Kuo J, Bristol JE. Haemophilus influenzae type b oxidized polysaccharide-outer membrane protein conjugate vaccine. U.S. Patent 5,192,540 dated March 9, 1993
